Researchers seek FDA approval for diabetes cell transplants

05/14/2013 | Denver Post, The

A consortium led by the University of Minnesota is preparing to seek FDA approval of a potential breakthrough treatment for type 1 diabetes that involves transplanting insulin-producing islet cells. Clinical studies have demonstrated that 60% to 70% of patients receiving the transplants remained insulin-free after five years. Approximately 1.5 million Americans have type 1 diabetes, in which the body destroys its own islet cells.

View Full Article in:

Denver Post, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN